GlassScriptPhysician profile
Alpen Patel
NPI 1780615344
$7,813.66
in general payments reported to CMS, 2019-2025
24 companies · $2,724 in 2025
The $2,724 reported for 2025 was more than what 93% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $680 · 2021: $685 · 2022: $771 · 2023: $724 · 2024: $2,229 · 2025: $2,724.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,384 · Travel and Lodging: $1,485 · Consulting Fee: $808.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,384.35 |
| Travel and Lodging | $1,485.07 |
| Consulting Fee | $807.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,074.15 | 2020-2025 | Inspire |
| Aerin Medical INC. | $1,992.67 | 2020-2025 | |
| Integra Lifesciences Corporation | $1,072.25 | 2024-2025 | Integra, Inspira Air, Acclarent Aera |
| Neurent Medical Limited | $837.16 | 2022-2024 | Neuromark Radiofrequency Console, Neuromark Device |
| Optinose US, INC. | $425.58 | 2020-2025 | |
| Glaxosmithkline, LLC. | $353.98 | 2020-2023 | Nucala |
| Medtronic USA, INC. | $150.00 | 2020 | |
| Acclarent, INC | $137.53 | 2020-2021 | |
| Alk-Abello, INC | $133.57 | 2020-2025 | Alternaria Tenuis, Standardized Mite D. Farinae, Timothy, Standardized |
| Sanofi-Aventis U.S. LLC | $81.48 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $67.96 | 2020-2023 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $64.86 | 2025 | |
| Medtronic, INC. | $59.00 | 2022 | |
| Stryker Corporation | $58.07 | 2020 | |
| Genzyme Corporation | $53.90 | 2023 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $53.66 | 2025 | Xhance |
| Intersect Ent, INC. | $30.67 | 2020 | |
| Zoll Respicardia, INC. | $29.13 | 2024 | Remede System |
| Biodelivery Sciences International, INC. | $27.18 | 2021 | |
| Hologic Sales and Service, LLC | $26.78 | 2024 | Coolseal Generator |
| Cochlear Americas | $23.32 | 2021 | |
| Smith+Nephew, INC. | $21.20 | 2020 | |
| Phadia US INC. | $20.15 | 2023 | Immunocap |
| Greer Laboratories, INC. | $19.41 | 2025 | Oralair |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alpen Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.